Scientific
and business
partners
Cell-Free Systems Innovations
The recombinant nature of proteins, and their ability to evolve and improve is also prevalent in the values of Synthelis. We develop our objectives based on a spirit of collaboration by looking for synergies with other Biotech companies, to best exploit our combined expertise. Innovation and collaboration go hand in hand. Whether you work in industry or academia, whether you work in research or funding we would be happy to talk with you about a future collaboration.
Our R&D partners
Our commercial partners
Peacel
A joint offering of in-silico protein engineering by Peaccel and protein sequences expression developed by Synthelis.
Hybrigenics
A joint offering of protein target production developed by Synthelis and the screening of a synthetic nanobody library by Hybrigenics.
MabSilico
A joint offering of in-silico antibody selection by MabSilico and the rapid sample production of each antibody by Synthelis.
Excilone
An analysis of the characteristics (size and composition) of proteoliposomes produced by Synthelis using Excilone instruments.
ALP-X
A gene-to-structure offering from the production of a protein to its crystallization to the determination of its three-dimensional structure.
ESRF
A gene-to-structure offering from the production of a protein to its crystallization to the determination of its three-dimensional structure.
A5 Science
A joint offering of custom production followed by validation of the protein folding and conformation using atomic force microscopy imaging.
join forces?
Let’s become
partners.
Even
a protein
needs
to express
its potential.